A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT06919965 · RECRUITING
Trial details
- NCT number
- NCT06919965
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2028-04-06
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.